Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Syndax Pharmaceuticals Inc shares valued at $25,037 were purchased by Goldan Keith A. on Jun 14 ’24. At $20.03 per share, Goldan Keith A. acquired 1,250 shares. The insider’s holdings grew to 52,623 shares worth approximately $1.16 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Morrison Briggs sold 52,855 shares, netting a total of over 965,402 in proceeds. Following the sale of shares at $18.27 each, the insider now holds 17,836 shares.
As published in their initiating research note from Jefferies on June 28, 2024, Syndax Pharmaceuticals Inc [SNDX] has been a Buy and the price target has been revised to $37. Analysts at Scotiabank downgraded the stock from ‘”a Sector outperform”‘ to ‘”a Sector perform”‘ outlook in a report released in late January. As of December 22, 2023, Mizuho has initiated its “Buy” rating for SNDX. Earlier on October 25, 2023, BofA Securities initiated its rating. Their recommendation was “a Buy” for SNDX stock.
Analyzing SNDX Stock Performance
During the last five days, there has been a drop of approximately -10.68%. Over the course of the year, Syndax Pharmaceuticals Inc shares have jumped approximately 1.80%. Shares of the company reached a 52-week high of $25.34 on 02/28/24 and a 52-week low of $18.65 on 06/06/24. A 50-day SMA is recorded $21.18, while a 200-day SMA reached $20.22. Nevertheless, trading volume fell to 1.32 million shares from 1.33 million shares the previous day.
Support And Resistance Levels for Syndax Pharmaceuticals Inc (SNDX)
According to the 24-hour chart, there is a support level at 21.65, which, if violated, would cause prices to drop to 21.31. In the upper region, resistance lies at 22.66. The next price resistance is at 23.33. RSI (Relative Strength Index) is 47.12 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.03, which suggests the price will decrease in the coming days. Percent R is at 66.45%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
